The European Union has approved funding for joint defence procurement by its member states for the first time in its history ... Source: European Pravda, citing the European Commission Details: EU ...

For adults with underlying medical conditions, RSV can worsen these conditions and lead to serious consequences. We are proud to be the first ... the US and the EU. GSK has also filed regulatory ...

AXA had said that it expected to close its acquisition of Nobis before the end of the first half of 2025.

"With Health Canada's approval of mRESVIA for Canadians aged 60 and older, we are proud to bring the first-ever mRNA vaccine against RSV to Canadians in a convenient and efficient pre-filled syringe ...

Pfizer's jab, meanwhile, is the only one of the three labelled for use as a maternal vaccine to prevent RSV in newborns and infants, although that is a much smaller market. The EU follows the US ...

TORONTO — Health Canada has approved Moderna's mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older — but it won't be available until next year, the company said on ...

TORONTO — Health Canada has approved Moderna's mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older — but it won't be available until next year, the company ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus, or RSV, in adults 60 years and older, making it the country's first authorized mRNA-based ...